Pinnacle Associates LTD Jazz Pharmaceuticals PLC Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 10,261 shares of JAZZ stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,261

Previous 10,338 0.74%

Holding current value

$1.24 Million

Previous $1.1 Million 3.63%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$100.57 - $116.37 $7,743 - $8,960	-77 Reduced 0.74%	10,261 $1.14 Million
Q2 2024 Jul 30, 2024	SELL	$103.94 - $118.98 $3,430 - $3,926	-33 Reduced 0.32%	10,338 $1.1 Million
Q1 2024 Apr 26, 2024	BUY	$115.19 - $132.77 $12,670 - $14,604	110 Added 1.07%	10,371 $1.25 Million
Q4 2023 Jan 19, 2024	SELL	$114.26 - $136.0 $37,248 - $44,336	-326 Reduced 3.08%	10,261 $1.26 Million
Q3 2023 Oct 23, 2023	BUY	$122.0 - $145.31 $29,036 - $34,583	238 Added 2.3%	10,587 $1.37 Million
Q2 2023 Jul 26, 2023	BUY	$122.5 - $147.16 $160,230 - $192,485	1,308 Added 14.47%	10,349 $1.28 Million
Q1 2023 May 04, 2023	BUY	$133.98 - $160.47 $477,102 - $571,433	3,561 Added 64.98%	9,041 $1.32 Million
Q4 2022 Jan 31, 2023	BUY	$129.72 - $159.85 $13,620 - $16,784	105 Added 1.95%	5,480 $873,000
Q4 2022 Jan 25, 2023	SELL	$129.72 - $159.85 $12,972 - $15,985	-100 Reduced 1.83%	5,375 $0
Q3 2022 Oct 31, 2022	SELL	$126.59 - $161.18 $18,988 - $24,177	-150 Reduced 2.67%	5,475 $730,000
Q2 2022 Aug 02, 2022	SELL	$141.59 - $168.66 $26,194 - $31,202	-185 Reduced 3.18%	5,625 $878,000
Q1 2022 May 05, 2022	BUY	$129.64 - $160.7 $509,485 - $631,551	3,930 Added 209.04%	5,810 $904,000
Q4 2021 Feb 02, 2022	BUY	$119.87 - $145.67 $16,901 - $20,539	141 Added 8.11%	1,880 $240,000
Q3 2021 Oct 19, 2021	BUY	$128.64 - $184.79 $33,446 - $48,045	260 Added 17.58%	1,739 $226,000
Q2 2021 Aug 02, 2021	BUY	$160.2 - $186.42 $22,267 - $25,912	139 Added 10.37%	1,479 $263,000
Q1 2021 May 12, 2021	SELL	$150.19 - $173.5 $15,019 - $17,350	-100 Reduced 6.94%	1,340 $220,000
Q3 2020 Oct 23, 2020	BUY	$105.46 - $144.13 $151,862 - $207,547	1,440 New	1,440 $205,000
Q1 2020 May 13, 2020	SELL	$87.74 - $152.74 $117,571 - $204,671	-1,340 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$117.65 - $153.73 $157,651 - $205,998	1,340 New	1,340 $200,000
Q3 2017 Nov 13, 2017	SELL	$142.62 - $155.6 $196,815 - $214,728	-1,380 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	1,380	1,380 $215,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.6B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Jazz Pharmaceuticals PLC Transaction History